Glucoheptonate measurement of differential renal function

Area of Science:

• Nuclear medicine
• Renal physiology
• Veterinary imaging

Background:

• Previous studies validated technetium-99m diethylenetriamine pentaacetic acid and dimercaptosuccinic acid for differential renal function measurement.
• Renal function asymmetry was induced in dogs via unilateral infarction or partial ureteral obstruction.

Purpose of the Study:

• To evaluate the efficacy of technetium-99m glucoheptonate in quantifying differential renal function.
• To compare its performance against established clearance methods in compromised renal models.

Main Methods:

• Technetium-99m glucoheptonate was administered intravenously to dogs with induced renal asymmetry.
• Dynamic imaging (2 sec/frame for 3 min) and static imaging (3-5 hours post-injection) were performed.
• Differential renal function was calculated from imaging data and compared with iothalamate and creatinine clearances.

Main Results:

• A strong correlation (r > 0.99) was observed between differential function calculated from the dynamic (1-3 min) bolus study and ureteral catheterization data.
• Static imaging showed less satisfactory correlation (r = 0.73) due to pelvic retention in obstructed kidneys.

Conclusions:

• Technetium-99m glucoheptonate is a reliable radiotracer for determining differential renal function.
• Dynamic imaging acquisition is superior to static imaging for this purpose in the presence of obstruction.